Bossa Laetitia, Kline Kimberly, McDougald Diane, Lee Bonsan Bonne, Rice Scott A
Neuroscience Research Australia (NEURA), Sydney, New South Wales, Australia.
The Singapore Centre for Environmental Life Sciences Engineering, The School of Biological Sciences, Nanyang Technological University, Singapore.
PLoS One. 2017 Jun 19;12(6):e0177633. doi: 10.1371/journal.pone.0177633. eCollection 2017.
The use of long-term catheterisation to manage insensate bladders, often associated with spinal cord injury (SCI), increases the risk of microbial colonisation and infection of the urinary tract. Urinary tract infection (UTI) is typically diagnosed and treated based on the culturing of organisms from the urine, although this approach overlooks low titer, slow growing and non-traditional pathogens. Here, we present an investigation of the urinary tract microbiome in catheterised SCI individuals, using T-RFLP and metagenomic sequencing of the microbial community. We monitored three neurogenic patients over a period of 12 months, who were part of a larger study investigating the efficacy of probiotics in controlling UTIs, to determine how their urinary tract microbial community composition changed over time and in relation to probiotic treatment regimens. Bacterial biofilms adherent to urinary catheters were examined as a proxy for bladder microbes. The microbial community composition of the urinary tract differed significantly between individuals. Probiotic therapy resulted in a significant change in the microbial community associated with the catheters. The community also changed as a consequence of UTI and this shift in community composition preceded the clinical diagnosis of infection. Changes in the microbiota due to probiotic treatment or infection were transient, resolving to microbial communities similar to their pre-treatment communities, suggesting that the native community was highly resilient. Based on these results, we propose that monitoring a patient's microbial community can be used to track the health of chronically catheterized patients and thus, can be used as part of a health-status monitoring program.
长期导尿用于管理通常与脊髓损伤(SCI)相关的感觉丧失膀胱,会增加微生物定植和尿路感染的风险。尿路感染(UTI)通常基于尿液中微生物的培养来诊断和治疗,尽管这种方法忽略了低滴度、生长缓慢和非传统病原体。在此,我们使用微生物群落的T-RFLP和宏基因组测序,对导尿的SCI个体的尿路微生物组进行了调查。我们对三名神经源性患者进行了为期12个月的监测,他们是一项更大规模研究的一部分,该研究旨在调查益生菌在控制UTI方面的疗效,以确定他们的尿路微生物群落组成如何随时间变化以及与益生菌治疗方案的关系。检查附着在导尿管上的细菌生物膜作为膀胱微生物的替代物。个体之间尿路的微生物群落组成存在显著差异。益生菌治疗导致与导管相关的微生物群落发生显著变化。由于UTI,群落也发生了变化,并且这种群落组成的变化先于感染的临床诊断。由于益生菌治疗或感染导致的微生物群变化是短暂的,会恢复到与其治疗前群落相似的微生物群落,这表明原生群落具有高度的恢复力。基于这些结果,我们建议监测患者的微生物群落可用于跟踪长期导尿患者的健康状况,因此可作为健康状况监测计划的一部分。